Get startedLog in
    Picture of ISR Immune System Regulation Holding AB (publ) logo

    ISR — ISR Immune System Regulation Holding AB (publ) News Story

    0.000.00%
    se flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro Cap
    All News

    Brief: ISR Plans New Study With HIV Patients

    Picture of ISR Immune System Regulation Holding AB (publ) logoISR Immune System Regulation Holding AB (publ)
    16/05/2019 09:31
    May 16 (Reuters) - ISR Immune System Regulation Holding
 ISR.ST :
    * SAID ON WEDNESDAY CO DECIDED TO START A STUDY IN HIV
PATIENTS
WITH RESISTANCE TO ANTIRETROVIRAL MEDICINE 
    * STUDY IS EXPECTED TO BEGIN IN Q4 2019 AND RUN FOR 6 MONTHS

    
 Source text for Eikon:  urn:newsml:reuters.com:*:nWkr6X7qXT
    
 Further company coverage:  ISR.ST  
   


 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920))

    Recent news on ISR Immune System Regulation Holding AB (publ)

    See all news